Rheumatoid arthritis-interstitial lung disease-associated mortality.
about
Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based ReviewManagement of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary FibrosisUp-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung DiseaseLung disease in rheumatoid arthritisThe multifaceted aspects of interstitial lung disease in rheumatoid arthritisInterstitial lung disease: raising the index of suspicion in primary careA roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung diseaseConnective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trialsNon-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.Case 238: Spontaneous Pneumothorax Secondary to Intrapulmonary Necrobiotic Rheumatoid Nodule.Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.Update in diffuse parenchymal lung disease 2011Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.A case of pulmonary fibrosis associated with rheumatoid arthritis, scleroderma sine scleroderma and ANCA associated vasculitis.Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.Sarcoidosis-related mortality in the United States from 1988 to 2007.Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseasesIncreased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.Smoking and Subclinical ILD in RA versus the Multi-Ethnic Study of AtherosclerosisSurvival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes.Clinical features of rheumatoid arthritis-associated interstitial lung disease.Biomarkers of rheumatoid arthritis-associated interstitial lung disease.Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study.Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD).Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.Respiratory mechanics measured by forced oscillation technique in rheumatoid arthritis-related pulmonary abnormalities: frequency-dependence, heterogeneity and effects of smoking.Outcome Measures for Clinical Trials in Interstitial Lung Diseases.Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice.Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.Rheumatoid arthritis in the Women's Health Initiative: methods and baseline evaluation.Predictors of mortality in rheumatoid arthritis-related interstitial lung disease.Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
P2860
Q26778887-3CFD1D0A-D1B1-4BB5-A291-03174DEC95E0Q26781712-BC3C29B3-ADF0-4D99-B7BB-266AC20FF23BQ26825098-1BC4B9F7-B377-4719-BAF3-08924AECC266Q26853575-929EE72F-1494-4D59-B854-407E54EC6120Q26861557-77EE9CB7-856D-4281-B171-C7ADA6027E31Q27001028-D2C33177-2D30-4969-A95D-B0412550C62DQ27014138-1AD30234-E298-4A3E-84B9-CCE701060DE3Q27024062-2DE4750B-DE8F-4028-8D53-F7256F163DE0Q31039549-63FC54A8-C90A-4632-8BA9-C2D03379BCB3Q33168153-BA970ACC-9615-49DC-9FB8-53ACA81C4AC4Q33717110-E0CAE37A-AA6F-482B-A96A-052F8CB75B1DQ33738931-2B8D7288-2DF8-445C-B3EC-50374038C9F1Q33829662-DD481228-418E-4D36-BFD0-C63B436B8F24Q33956830-946A5E96-8679-46AA-8367-C5796F95FD52Q34217084-FCF60127-4C07-48EF-A11D-59B5F6940DA2Q34947978-7602D9C6-B122-4AD2-814B-B915E72F5A65Q35107684-63164183-C4EF-4489-BBF6-2D87ADD5B0D5Q35151573-37161B6D-9BFB-449B-9224-D73BD75457A7Q35206414-85DFC2DF-9E9D-407D-B910-024C1454D51DQ35497307-00A2706C-52B7-45A1-86A8-612AEC5D8DEFQ35755282-229B0CF3-3991-4282-8C41-9D3D4EA2E8FBQ35766847-D0F10D76-957B-4BEF-9FF3-543B3049E54EQ35981104-0B79868B-9740-4213-8688-3FF6D0D3E4D7Q36076614-8006266B-4E10-4B4C-B79A-4CAB6E7D5707Q36086758-5918F3A7-7A82-4CBE-BA96-219C37A60AB7Q36128529-B0477DA7-A559-4F33-9B85-12CCBB2CD5A3Q36218552-6066593A-9DC0-4E69-A070-AE8F689D0873Q36270376-7E88F0AD-CE00-43BF-80C4-41F3A7669146Q36277227-CCD245F8-84F4-440A-A531-F22548EA8F0AQ36306270-36643F5E-6894-4750-8F15-11D96BD7C68EQ36664408-A09FDBF8-187B-4EDC-AE28-2117D2372CA5Q36689851-2BE8900F-D336-411C-95C3-7BBE57B24A93Q36726418-CA30416A-102D-4278-B249-34E61A78721FQ36902118-00774E41-6E30-4B32-9F56-804EB90164E6Q37445635-C8012607-1E6F-4CBE-A677-1EFFD9868011Q37671914-94B4BE1A-DF59-416C-BE2C-3195831FBA59Q38174219-CE3E972A-6712-4F6F-89C7-53296E20921DQ38191199-0B699FB2-2E28-4EAD-9428-6D516378631BQ38642378-DB14626B-95AA-422F-9369-D7CD14FEB780Q38658483-AB1BA9B4-4A33-47A5-BDEC-5494E4191C3C
P2860
Rheumatoid arthritis-interstitial lung disease-associated mortality.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rheumatoid arthritis-interstitial lung disease-associated mortality.
@ast
Rheumatoid arthritis-interstitial lung disease-associated mortality.
@en
type
label
Rheumatoid arthritis-interstitial lung disease-associated mortality.
@ast
Rheumatoid arthritis-interstitial lung disease-associated mortality.
@en
prefLabel
Rheumatoid arthritis-interstitial lung disease-associated mortality.
@ast
Rheumatoid arthritis-interstitial lung disease-associated mortality.
@en
P2093
P2860
P1476
Rheumatoid arthritis-interstitial lung disease-associated mortality
@en
P2093
Amy L Olson
Aryeh Fischer
David B Sprunger
Ganesh Raghu
James Murphy
Jeffrey J Swigris
Josh Solomon
Kevin K Brown
Marc Cohen
P2860
P304
P356
10.1164/RCCM.201004-0622OC
P407
P577
2010-09-17T00:00:00Z